Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.

Brigitte Mlineritsch; Renate Schabel-Moser; Johannes Andel; Michael Fridrik; Martin Moik; Peter Mayer; Gudrun Russ; Christoph Rass; Richard Greil

doi:10.1159/000180915

Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.

Brigitte Mlineritsch (First author), Renate Schabel-Moser, Johannes Andel, Michael Fridrik, Martin Moik (Co-author), Peter Mayer, Gudrun Russ (Co-author), Christoph Rass (Co-author), Richard Greil^* (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

13 Citations (Web of Science)

Original language	English
Pages (from-to)	18-24
Journal	ONKOLOGIE
Volume	32
Issue number	1-2
DOIs	https://doi.org/10.1159/000180915
Publication status	Published - 2009

Keywords

QUALITY-OF-LIFE
EUROPEAN-ORGANIZATION
PRETREATED PATIENTS
TRIAL
CARDIOTOXICITY
ANTHRACYCLINES
THERAPY
WOMEN
CHEMOTHERAPY
PACLITAXEL

Access to Document

10.1159/000180915

Cite this

Mlineritsch, B., Schabel-Moser, R., Andel, J., Fridrik, M., Moik, M., Mayer, P., Russ, G., Rass, C., & Greil, R. (2009). Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer. ONKOLOGIE , 32(1-2), 18-24. https://doi.org/10.1159/000180915

Mlineritsch, Brigitte ; Schabel-Moser, Renate ; Andel, Johannes et al. / Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer. In: ONKOLOGIE 2009 ; Vol. 32, No. 1-2. pp. 18-24.

@article{58ccd603a1d3449b8b1d6d7d08e115a1,

title = "Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.",

keywords = "QUALITY-OF-LIFE, EUROPEAN-ORGANIZATION, PRETREATED PATIENTS, TRIAL, CARDIOTOXICITY, ANTHRACYCLINES, THERAPY, WOMEN, CHEMOTHERAPY, PACLITAXEL",

author = "Brigitte Mlineritsch and Renate Schabel-Moser and Johannes Andel and Michael Fridrik and Martin Moik and Peter Mayer and Gudrun Russ and Christoph Rass and Richard Greil",

note = "Paracelsus Med Univ Salzburg, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, Salzburg, Austria Paracelsus Med Univ Salzburg, Lab Immunol & Mol Canc Res, Salzburg, Austria",

year = "2009",

doi = "10.1159/000180915",

language = "English",

volume = "32",

pages = "18--24",

journal = "ONKOLOGIE ",

issn = "0378-584X",

number = "1-2",

}

Mlineritsch, B, Schabel-Moser, R, Andel, J, Fridrik, M, Moik, M, Mayer, P, Russ, G, Rass, C & Greil, R 2009, 'Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.', ONKOLOGIE , vol. 32, no. 1-2, pp. 18-24. https://doi.org/10.1159/000180915

Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer. / Mlineritsch, Brigitte (First author); Schabel-Moser, Renate; Andel, Johannes et al.
In: ONKOLOGIE , Vol. 32, No. 1-2, 2009, p. 18-24.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.

AU - Mlineritsch, Brigitte

AU - Schabel-Moser, Renate

AU - Andel, Johannes

AU - Fridrik, Michael

AU - Moik, Martin

AU - Mayer, Peter

AU - Russ, Gudrun

AU - Rass, Christoph

AU - Greil, Richard

N1 - Paracelsus Med Univ Salzburg, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, Salzburg, Austria Paracelsus Med Univ Salzburg, Lab Immunol & Mol Canc Res, Salzburg, Austria

PY - 2009

Y1 - 2009

KW - QUALITY-OF-LIFE

KW - EUROPEAN-ORGANIZATION

KW - PRETREATED PATIENTS

KW - TRIAL

KW - CARDIOTOXICITY

KW - ANTHRACYCLINES

KW - THERAPY

KW - WOMEN

KW - CHEMOTHERAPY

KW - PACLITAXEL

U2 - 10.1159/000180915

DO - 10.1159/000180915

M3 - Original Article

C2 - 19209014

SN - 0378-584X

VL - 32

SP - 18

EP - 24

JO - ONKOLOGIE

JF - ONKOLOGIE

IS - 1-2

ER -

Mlineritsch B, Schabel-Moser R, Andel J, Fridrik M, Moik M, Mayer P et al. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer. ONKOLOGIE . 2009;32(1-2):18-24. doi: 10.1159/000180915